These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9160072)

  • 21. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E; Kefalopoulou Z; Georgiopoulos M; Paschali A; Constantoyannis C
    Clin Neurol Neurosurg; 2010 May; 112(4):344-6. PubMed ID: 20061080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological study in Meige's syndrome with predominant blepharospasm.
    Ransmayr G; Kleedorfer B; Dierckx RA; Poewe W; Kemmler GW; Gerstenbrand F
    Clin Neuropharmacol; 1988 Feb; 11(1):68-76. PubMed ID: 3280128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin in the treatment of lingual movement disorders.
    Kasravi N; Jog MS
    Mov Disord; 2009 Nov; 24(15):2199-202. PubMed ID: 19795478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A; Meindl T; Huber C; Mantel T; Zwirner S; Castrop F; Haslinger B
    J Neurol; 2020 Jan; 267(1):267-275. PubMed ID: 31630241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome.
    Møller E; Werdelin LM; Bakke M; Dalager T; Prytz S; Regeur L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Nov; 96(5):544-9. PubMed ID: 14600688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-refractory schizophrenia in a patient who previously suffered from Meige's syndrome.
    Uemura T; Mochida M; Matsumi T; Yoshimoto K; Tatebayashi Y
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):297-300. PubMed ID: 31743613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.
    Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T
    Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407
    [No Abstract]   [Full Text] [Related]  

  • 37. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S; Sharma S
    J Neurol Sci; 2017 Jan; 372():162-170. PubMed ID: 28017205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics.
    Hípola D; Mateo D; Giménez-Roldán S
    Eur Neurol; 1984; 23(6):474-8. PubMed ID: 6510447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.